← Back
Data updated: Jul 17, 2026
QINGDAO BAHEAL PHARM
Generics Pharmaceuticals
QINGDAO BAHEAL PHARM is a generic drug manufacturer with 3 FDA-approved products.
2018
Since
3
Drugs
-
Trials
1
New Drugs (2yr)
QINGDAO BAHEAL PHARM's Key Drugs
QINGDAO BAHEAL PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
QINGDAO BAHEAL PHARM's Recent FDA Approvals
QINGDAO BAHEAL PHARM secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
QINGDAO BAHEAL PHARM's Therapeutic Areas
Disease areas where QINGDAO BAHEAL PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
QINGDAO BAHEAL PHARM Pipeline Snapshot
Active clinical trials for QINGDAO BAHEAL PHARM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2018-12-27
- Latest
- 2026-02-12
- Applications
- 3